Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 11,244 | 388 | 0 | 0 | 0 |
| Cost of Goods | 4,383 | 3,575 | N/A | N/A | N/A |
| Gross Profit | 6,861 | -3,187 | N/A | N/A | N/A |
| Operating Expenses | 37,210 | 29,357 | 24,171 | 34,164 | 9,771 |
| Operating Income | -29,966 | -31,969 | -24,171 | -34,164 | -9,771 |
| Other Income | 968 | 529 | 1,757 | 2,080 | 344 |
| Pre-tax Income | -28,998 | -31,440 | -22,414 | -32,084 | -9,427 |
| Net Income Continuous | -28,998 | -31,440 | -22,414 | -32,084 | -9,427 |
| Net Income | $-28,998 | $-31,440 | $-22,414 | $-32,084 | $-9,390 |
| EPS Basic Total Ops | -3.60 | -4.10 | -3.00 | -4.80 | -3.20 |
| EPS Basic Continuous Ops | -3.58 | -4.09 | -2.95 | -4.78 | -3.20 |
| EPS Diluted Total Ops | -3.60 | -4.10 | -3.00 | -4.80 | -3.20 |
| EPS Diluted Continuous Ops | -3.58 | -4.09 | -2.95 | -4.78 | -3.20 |
| EBITDA(a) | $-26,833 | $-29,979 | $-22,870 | $-33,405 | $-9,269 |